Advanced search
Publication Cover
International Journal of Nephrology and Renovascular Disease Volume 6, 2013 - Issue
Submit an article Journal homepage
58
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clinical management of nondialysis patients with chronic kidney disease: a retrospective observational study. Data from the SONDA study (Survey Of Non-Dialysis outpAtients)

Massimo Morosetti1 Nephrology and Dialysis Department, ‘G.B. Grassi’ Hospital, Ostia Lido, Rome, Italy
,
Antonio Gorini2 Abbott S.r.l., Campoverde (LT), Rome, Italy
,
Anna Maria Costanzo2 Abbott S.r.l., Campoverde (LT), Rome, ItalyCorrespondence[email protected]
,
Silvia Cipriani1 Nephrology and Dialysis Department, ‘G.B. Grassi’ Hospital, Ostia Lido, Rome, Italy
,
Sara Dominijanni1 Nephrology and Dialysis Department, ‘G.B. Grassi’ Hospital, Ostia Lido, Rome, Italy
,
Colin G Egan3 Primula Multimedia S.r.l., Pisa, Italy
,
Laura Zappalà1 Nephrology and Dialysis Department, ‘G.B. Grassi’ Hospital, Ostia Lido, Rome, Italy
&
Umberto di Luzio Paparatti2 Abbott S.r.l., Campoverde (LT), Rome, Italy
 show all
Pages 27-37 | Published online: 18 Feb 2013

Figures & data

Table 1 Baseline clinical characteristics by staging of CKD in total population (n = 397)

Figure 1 Staging and variation in CKD staging for patients over the four visits. (A) Staging of CKD in patients over the four visits. (B) Change in CKD staging (relative to baseline) over the four visits.

Note: Data are expressed as percentage and taken from patients who attended all four visits (n = 92).
Figure 1 Staging and variation in CKD staging for patients over the four visits. (A) Staging of CKD in patients over the four visits. (B) Change in CKD staging (relative to baseline) over the four visits.

Figure 2 Concomitant diseases diagnosed in patients over the four visits.

Notes: Data are expressed as percentage and taken from the total population (n = 397). P values are indicated where significant differences were observed over the four visits (Fisher’s exact test).
Figure 2 Concomitant diseases diagnosed in patients over the four visits.

Figure 3 Treatment and adverse events in patients over the four visits. (A) Medication received in patients over the four visits. (B) Adverse events reported in patients over the four visits.

Notes: Data are expressed as percentage and taken from patients who attended all four visits (n = 92). P value indicates a significant difference observed over the four visits (Fisher’s exact test).
Figure 3 Treatment and adverse events in patients over the four visits. (A) Medication received in patients over the four visits. (B) Adverse events reported in patients over the four visits.

Table 2 Clinical characteristics for patients that attended four visits

Table 3 Range in hemoglobin levels in patients over the four visits

Figure 4 Use of EPO to treat anemia in patients over the four visits. Proportion of patients receiving EPO medication by different levels of Hb over the four visits.

Notes: Data are expressed as percentage and taken from patients who attended all four visits (n = 92). P value indicates a significant difference observed over the four visits (Fisher’s exact test).
Abbreviations: EPO, erythropoietin; Hb, hemoglobin.
Figure 4 Use of EPO to treat anemia in patients over the four visits. Proportion of patients receiving EPO medication by different levels of Hb over the four visits.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.